DOMESTIC MYOCARDIAL CYTOPROTECTOR EFFECTIVENESS AND ITS PHARMACODYNAMICS IN ACUTE MYOCARDIAL ISCHEMIA: CLINICAL RESULTS AND EXPERIMENTAL MODELS

Anti-ischemic effects of high-dose cardiac cytoprotector Mexicor (0,014 g/kg/d, 0,019 g/kg/d) were examined in rabbits with experimental myocardial infarction. In addition, anti-ischemic activity of Mexicor (0,4 g/d) was assessed in patients with acute coronary syndrome (ACS). It has been demonstrat...

Full description

Saved in:
Bibliographic Details
Main Authors: V. P. Mikhin, M. V. Pokrovskyi, V. V. Gureev, O. A. Chernova, Yu. V. Alimenko, E. N. Bogoslovskaya
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2011-04-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/1101
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Anti-ischemic effects of high-dose cardiac cytoprotector Mexicor (0,014 g/kg/d, 0,019 g/kg/d) were examined in rabbits with experimental myocardial infarction. In addition, anti-ischemic activity of Mexicor (0,4 g/d) was assessed in patients with acute coronary syndrome (ACS). It has been demonstrated that Mexicor reduced the size of infarction area and decreased the ratio “necrosis area / ischemia area”, compared to the control animals. In ACS patients, Mexicor facilitated faster recovery of left ventricular diastolic function, and also decreased blood levels of NT-proBNP.
ISSN:1560-4071
2618-7620